• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human RPA-interacting protein (RPAIN)

ACP15419

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15419 Target NameRPAIN
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-219Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ86UA6
Background Information
  • Uniprot Id

    Q86UA6

  • Target Species

    Human

  • Target Name

    RPAIN

  • Target Full Name

    RPA-interacting protein

  • Target Function

    Mediates the import of RPA complex into the nucleus, possibly via some interaction with importin beta. Isoform 2 is sumoylated and mediates the localization of RPA complex into the PML body of the nucleus, thereby participating in RPA function in DNA metabolism.

  • Target Subcellular Location

    [Isoform 1]: Cytoplasm. Nucleus.; [Isoform 2]: Nucleus, PML body.

  • Target Tissue Specificity

    Widely expressed. Expressed in pancreas, kidney, muscle, liver, lung, placenta, brain, heart, leukocytes, colon, intestine, ovary, testis, prostate, thymus and spleen.

  • Target Synonyms

    2400006N03Rik; DN-393H17.1; FLJ25625; FLJ30490 ; FLJ42429 ; HRIP; MGC4189 ; Nuclear transporter; RAP interaction protein; RIP ; RIP_HUMAN; RP23 83I13.5; RPA interacting protein; RPA-interacting protein; Rpain

Inquire Recombinant Human RPA-interacting protein (RPAIN) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification